Skip to main content

FDI IN PHARMACEUTICALS

PHARMACEUTICALS

The Country is Largest Vaccine Producer in The World

FDI in Pharmaceuticals in India

India enjoys an important position in the global pharmaceuticals sector with a 20% share of generic medicines in supplies by volume. Indian pharmaceutical sector industry supplies over 50 percent of global demand for various vaccines, 40% of generic demand in the US, and 25% of all medicine in the UK.

India is the source of 60,000 generic brands across 60 therapeutic categories and manufactures more than 500 different Active Pharmaceutical Ingredients (APIs). The export of generic drugs is one of India's core strengths. The country’s pharmaceutical exports stood at US$ 17.27 billion in FY18 and have reached US$ 19.14 billion in FY19.  Presently over 80% of the antiretroviral drugs used globally to combat AIDS are supplied by Indian pharmaceutical firms.

100% Foreign Direct Investment (FDI) in pharmaceuticals in India is allowed under the automatic route for green-field pharma.

100% Fdi In Drugs And Pharmaceuticals In India is allowed in brownfield pharma; wherein 74% FDI in the Pharmaceuticals Sector is allowed under the automatic route and thereafter through government approval route.



INDUSTRY SCENARIO

  • The pharmaceutical industry was valued at $ 36.7 bn in 2018. The country’s pharmaceutical industry is expected to expand at a CAGR of 22.4% over 2015–20 to reach USD $55 bn
  • India’s pharmaceutical exports stood at USD $17.27 bn in FY18 and have reached USD $15.52 bn in FY19 (up to January 2019)
  • The Pharmaceutical industry in India accounts for about 2.4% of the global Pharmaceutical industry in value terms
  • Indian companies received 304 Abbreviated New Drug Application (ANDA) approvals from the US Food and Drug Administration (USFDA) in 2017. The country accounts for around 30% (by volume) and about 10% (value) in the USD $70-80 bn US generics market
  • Generic drugs with 70% market share form the largest segment of the Pharmaceutical industry in India. Over-the-counter (OTC) medicines constitute around 21% of the market while patented drugs have a 9% share
  • India is currently among the top 20 global Medical device markets and the 4th largest medical device market in Asia


RECENT INVESTMENTS IN INDIA : 

  •  May 2019: Online pharmacy Medlife has acquired Bengaluru-based medicine delivery start up Myra. Medlife will use the delivery segment to expand its services to 22 cities.
  • Feb 2019: Indian pharmaceutical market grew by 10% year-on-year.
  • Oct 2018: Active pharmaceutical ingredients (APIs) and drug intermediates maker Divis Laboratories Limited is creating additional capacities by spending as much as Rs.15000 crores at its existing facilities in the next 15 months
  • Sep 2018: Indian pharma sector witnessed 39 PE investment deals worth USD $217 mn.
  • Jul 2018: Swiss pharma giant Ferring Pharmaceuticals will be investing $250 mn in setting up a manufacturing facility and R&D centre in the city’s life sciences hub of Genome Valley.
  • Jun 2018: Tyumen has joined a growing list of Russian regions keen on playing host to pharmaceutical ventures of Indian firms, a move that comes in the backdrop of Russia’s emphasis on building self-reliance in drug production.
  • $16.2 bn FDI in pharmaceuticals in drugs & pharmaceuticals during April 2000 – June 2019
  • 100 per cent FDI in pharma sector allowed in green-field pharma
  • 74% FDI in the pharmaceuticals sector is allowed for brownfield pharmaceuticals projects



Labels:
Location: Hyderabad, Telangana, India

Comments

Post a Comment

Popular posts from this blog

Liberalisation of FDI In Insurance Companies

Liberalization of FDI In Insurance Companies – A Look at the Step(s) Taken Since the Big Budget Announcement. The industry is now well versed with the move to liberalize foreign direct investment (“ FDI ”) in Indian insurance companies to 74%, from the existing cap of 49%. The announcement was first made by the Finance Minister Ms. Nirmala Sitharaman on February 1, 2021, as part of her Budget presentation. The move followed the rise in FDI limits to 100% in insurance intermediaries, which was announced by Ms. Sitharaman in July 2019 and effected in September 2019. It appears that the government is now acting swiftly with the legislative changes to effect the proposal to increase FDI in insurance companies to 74%. Both houses of the Indian Parliament recently assented to the Insurance (Amendment) Bill, 2021 (“ Amendment Bill ”), to amend the Insurance Act, 1938 (“ Insurance Act ”). The Rajya Sabha passed the Amendment Bill on March 18, 2021, while the Lok Sabha passed the Amendment Bill...
Post a Comment
Read more

Here Is All That You Need To Know About - The New Education System In India

Another important day to be marked in the history of making India a global superpower.  Long-awaited,  the new education policy  was approved by the Union Cabinet at a meeting presided by Prime Minister  Narendra Modi  on Wednesday, 29th July 2020.  The new education system aims at bringing in transformation reforms in the education system of schools and higher education. Replacing the 34-year old education system is another major move in the direction of strengthening India as a global power.  During the tenure of former Prime Minister Rajiv Gandhi, in 1985, the Ministry of Education was assigned a new name as the Human Resource Development (HRD). And the National Education System (NEP) was formed in 1986. Former Prime Minister PV Narsimha Rao was the first HRD minister under the Rajiv Gandhi Cabinet.  The new NEP also includes the renaming of the HRD Ministry back to the Education Ministry. Promoting the spirit of “Ek Bharat Shreshtha Bharat”, P...
1 comment
Read more

Monetary Policy Design.

How should governments and central banks use monetary policy to create a healthy economy? Traditionally, policymakers have used such strategies as controlling the growth of the money supply or pegging the exchange rate to a stable currency. In recent years, a promising new approach has emerged: publicly announcing and pursuing specific targets for the rate of inflation. This book is the first in-depth study of inflation targeting. Combining penetrating theoretical analysis with detailed empirical studies of countries where inflation targeting has been adopted, the authors show that the strategy has clear advantages over traditional policies.… The authors argue that the simplicity and openness of inflation targeting make it far easier for the public to understand the intent and effects of monetary policy. This strategy also increases policymakers’ accountability for inflation performance and can accommodate flexible, even ‘discretionary’, monetary policy actions without sacrificing cent...
Post a Comment
Read more